Cilostazol mitigates amiodarone-induced pulmonary toxicity and fibrosis by regulating the cAMP/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition in rats. [PDF]
El-Gammal MA +4 more
europepmc +1 more source
Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease. [PDF]
Lin CW +7 more
europepmc +1 more source
Real-world risk assessment of combined cilostazol-rosuvastatin: a retrospective cohort study using Korean electronic health records. [PDF]
Shin WY, Jang HY, Lee K.
europepmc +1 more source
Deconvolution of Red Blood Cells Thermal Fluid Biopsy Following Systematic Cyclophosphamide or Cilostazol Drug Therapies. [PDF]
Ferencz A, Lőrinczy D.
europepmc +1 more source
Cilostazol Conduction Effects: A Possible Adjunctive Therapy Option? [PDF]
Haloot J, Birnbaum Y.
europepmc +1 more source
Cilostazol for heart rate increase in atrial fibrillation with slow ventricular response: an exploratory randomized controlled trial. [PDF]
Berbert GH +5 more
europepmc +1 more source
Adjuvant Cilostazol Therapy to Help Restore Atrioventricular Conduction in Lyme Carditis. [PDF]
Aryal B, Mandal P, Meyer MF.
europepmc +1 more source
Protective effects of cilostazol against cisplatin-induced hepatorenal toxicity in male mice. [PDF]
Hakimizadeh E +5 more
europepmc +1 more source
Exploration of the Role of Cilostazol in Brugada Syndrome: Mechanisms, Therapeutic Potential, and Implications in the Prevention of Ventricular Arrhythmias. [PDF]
Iqbal M, Putra ICS, Karwiky G, Achmad C.
europepmc +1 more source
A Critical Review of the Molecular and Clinical Effects of Cilostazol After Percutaneous Coronary Intervention. [PDF]
Ferrari R, Perrone Filardi P.
europepmc +1 more source

